SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Notes Payable, Current
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Notes Payable, Current of $190.27 thousand as of 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2026-03-31
- 2024-12-31: Notes Payable, Current $190.27K.
- 2023-03-31: Notes Payable, Current $139.23K.
- 2022-12-31: Notes Payable, Current $685.47K.
| Period end | Notes Payable, Current |
|---|---|
| 2024-12-31 | $190.27K 10-K · filed 2026-03-31 |
| 2023-03-31 | $139.23K 10-Q · filed 2023-05-25 |
| 2022-12-31 | $685.47K 10-Q · filed 2023-05-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |